Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
XTL Biopharmaceuticals Ltd
XTLB | US
0.70
USD-0.03
-3.58%
XTLB | US
Loading StockChartView...
About XTL Biopharmaceuticals Ltd
Sector
Healthcare
Industry
Biotechnology
Earnings date
31/03/2024
As of date
09/03/2026
Close
0.70
Open
0.74
High
0.75
Low
0.70
XTL Biopharmaceuticals Ltd. a biopharmaceutical company engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. Its lead drug candidate is hCDR1 a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research development and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan Israel.
View LessXTLB | US
Risk
74.2
Sharpe
-0.40
Luna's Score
34/100
Recommendation
Sell
Luna says (XTLB | US)
What's Working
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
75.6%1 month
74.2%3 months
154.1%6 months
145.1%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
4.37
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
16.54
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-764.00K
MarketCap
3.83M
MarketCap(USD)
3.83M
Div. yield
-
Op. margin
-
Erngs. growth
-76.00
Rev. growth
-
Ret. on equity
-13.07
Short ratio
2.30
Short perc.
1.02
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.19
Range1M
0.40
Range3M
0.88
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.23
Price X volume
7.67K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 16.54 | 0.53 | Expensive |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 4.37 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 154.14 | 72.80 | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 3.83M | 3.66B | Emerging |
